WallStreetZenWallStreetZen

NASDAQ: PRE
Prenetics Global Ltd Stock Forecast, Predictions & Price Target

Analyst price target for PRE

Based on 2 analysts offering 12 month price targets for Prenetics Global Ltd.
Min Forecast
$7.00+345.86%
Avg Forecast
$11.00+600.64%
Max Forecast
$15.00+855.41%

Should I buy or sell PRE stock?

Based on 2 analysts offering ratings for Prenetics Global Ltd.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PRE stock forecasts and price targets.

PRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Top 47%
54
Strong BuyInitiates Coverage On$7.00+345.86%2023-01-18
Ladenburg Thalmann
Bottom 1%
1
Strong BuyInitiates Coverage On$15.00+855.41%2022-05-02

1 of 1

Forecast return on equity

Is PRE forecast to generate an efficient return?
Company
-2.14%
Industry
-20.91%
Market
47.78%
PRE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PRE forecast to generate an efficient return on assets?
Company
-1.65%
Industry
12.04%
PRE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PRE earnings per share forecast

What is PRE's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.07
Avg 2 year Forecast
-$0.04

PRE vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
PRE$1.57$11.00+600.64%Strong Buy
PSNL$3.88$9.50+144.85%Buy
STIM$6.10$10.00+63.93%Buy
CELC$10.38$25.00+140.85%Buy
LAB$2.02$10.00+395.05%Strong Buy

Prenetics Global Stock Forecast FAQ

Is Prenetics Global Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PRE) stock is to Strong Buy PRE stock.

Out of 2 analysts, 2 (100%) are recommending PRE as a Strong Buy, 0 (0%) are recommending PRE as a Buy, 0 (0%) are recommending PRE as a Hold, 0 (0%) are recommending PRE as a Sell, and 0 (0%) are recommending PRE as a Strong Sell.

If you're new to stock investing, here's how to buy Prenetics Global stock.

What is PRE's earnings growth forecast for 2023-2024?

(NASDAQ: PRE) Prenetics Global's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 33.33%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 85.2%.

Prenetics Global's earnings in 2023 is -$358,340,505.On average, 1 Wall Street analyst forecast PRE's earnings for 2023 to be -$7,768,554, with the lowest PRE earnings forecast at -$7,768,554, and the highest PRE earnings forecast at -$7,768,554.

In 2024, PRE is forecast to generate -$4,439,174 in earnings, with the lowest earnings forecast at -$4,439,174 and the highest earnings forecast at -$4,439,174.

What is PRE's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: PRE) forecast ROE is -2.14%, which is considered weak.

What is PRE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PRE price target, the average PRE price target is $11.00, with the highest PRE stock price forecast at $15.00 and the lowest PRE stock price forecast at $7.00.

On average, Wall Street analysts predict that Prenetics Global's share price could reach $11.00 by Jan 18, 2024. The average Prenetics Global stock price prediction forecasts a potential upside of 600.64% from the current PRE share price of $1.57.

What is PRE's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: PRE) Prenetics Global's current Earnings Per Share (EPS) is -$14.10. On average, analysts forecast that PRE's EPS will be -$0.07 for 2023, with the lowest EPS forecast at -$0.07, and the highest EPS forecast at -$0.07. In 2024, PRE's EPS is forecast to hit -$0.04 (min: -$0.04, max: -$0.04).

What is PRE's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: PRE) forecast ROA is -1.65%, which is lower than the forecast US Diagnostics & Research industry average of 12.04%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.